The company
Alkermes plc -
ALKS · Nasdaq
ALKS stood above a rising 150-day average in 33 of the last 52 weekly readings, including each of the last 1 week. It is 0.9% above that average now. Pharmaceuticals: 32% of its 74 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Just started moving
- Weeks in an uptrend
- 1 in a row
- Industry in uptrend
- 32% -7 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $20.0M
- Officials’ trades on record
- 8
- Institutions holding
- 391 (+32)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 33 of 52 weeks.
Pharmaceuticals: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
8 disclosed lines: House 2, Senate 0, executive 6; 2 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | bought | $1k–$15k | 29 Sep 2026filed 12 Oct 2026 |
| Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31 | bought | $15k–$50k | 30 Jul 2026filed 4 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $50k–$100k | 29 Jul 2026filed 22 Sep 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $1k–$15k | 15 Jun 2026filed 22 Aug 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $1k–$15k | 15 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $50k–$100k | 30 Mar 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 26 Feb 2026filed 14 May 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 26 Jan 2026filed 14 May 2026 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| David Joseph GaffinEVP, CLO, Alkermes, Inc. | sold | 2,034at $41.03 | 2 Oct 2026filed 2 Oct 2026 |
| David Joseph GaffinEVP, CLO, Alkermes, Inc. | sold | 2,034at $48.01 | 3 Sep 2026filed 3 Sep 2026 |
| Craig C. HopkinsonEVP R&D, Chief Medical Officer | sold | 9,000at $46.99 | 1 Sep 2026filed 1 Sep 2026 |
| Christian Todd NicholsSVP, Chief Commercial Officer | sold | 6,912at $49.19 | 17 Aug 2026filed 17 Aug 2026 |
| Christian Todd NicholsSVP, Chief Commercial Officer | sold | 664at $49.65 | 17 Aug 2026filed 17 Aug 2026 |
| David Joseph GaffinEVP, CLO, Alkermes, Inc. | sold | 2,034at $48.58 | 3 Aug 2026filed 3 Aug 2026 |
| Craig C. HopkinsonEVP R&D, Chief Medical Officer | sold | 9,000at $48.58 | 3 Aug 2026filed 3 Aug 2026 |
| Nancy Lynn Md SnydermanDirector | sold | 44,472at $50.35 | 3 Aug 2026filed 3 Aug 2026 |
| David Joseph GaffinEVP, CLO, Alkermes, Inc. | sold | 2,034at $54.03 | 6 Jul 2026filed 6 Jul 2026 |
| Craig C. HopkinsonEVP R&D, Chief Medical Officer | sold | 8,300at $51.46 | 1 Jul 2026filed 1 Jul 2026 |
| Craig C. HopkinsonEVP R&D, Chief Medical Officer | sold | 700at $52.13 | 1 Jul 2026filed 1 Jul 2026 |
| Christopher I. WrightDirector | sold | 2,000at $45.10 | 12 Jun 2026filed 12 Jun 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 29,235,739$1.5B | +921,329+3.3% |
| BAKER BROS. ADVISORS LPunchanged · filed 14 Aug 2026 | 10,012,267$524.6M | 00.0% |
| VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 2026 | 9,490,818$497.3M | -20,294−0.2% |
| STATE STREET CORPreduced · filed 7 Aug 2026 | 9,160,575$480.0M | -304,711−3.2% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 7,515,025$393.7M | +87,628+1.2% |
| RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026 | 6,460,928$338.5M | +300,500+4.9% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 4,477,876$234.7M | +295,609+7.1% |
| DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 2026 | 4,194,873$219.8M | -327,505−7.2% |
| Deep Track Capital, LPadded · filed 14 Aug 2026 | 4,000,000$209.6M | +409,677+11.4% |
| AMERICAN CENTURY COMPANIES INCreduced · filed 12 Aug 2026 | 3,954,239$207.2M | -2,117,864−34.9% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.